MedPath

AVENIR project:: AGE in Vascular risk Estimation and Normalisation by Intensified Reduction in diabetes type 2

Completed
Conditions
diabetic cardiovascular complications
10012653
Registration Number
NL-OMON34555
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
930
Inclusion Criteria

type 2 diabetes mellitus

Exclusion Criteria

factors which may affect UKPDS risk engine score or autofluorescence measurement, such as South Asian descent, diffuse skin dsease

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The difference in reduction from baseline to the end of the study (one year)<br /><br>in systolic blood pressure and in blood pressure, lipid lowering and<br /><br>anitdiabetic medication between the two arms. Systolic blood pressure has been<br /><br>used for power analysis. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath